TrialBMC cancer2019

Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm study.

Xiaoyang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.